Özalp, Veli Cengiz

Profile Picture
Name Variants
Ozalp, Cengiz
Özalp, Veli C.
Özalp V.
Özalp,V.C.
V. C. Ozalp
Ozalp, Veli C.
V.,Özalp
Cengiz Özalp, Veli
V.C.Özalp
Ozalp, Cengiz Vali
Özalp, Veli Cengiz
Veli Cengiz, Ozalp
O., Veli Cengiz
Veli Cengiz, Özalp
Ozalp, Veli Cengiz
V. C. Özalp
Cengiz Özalp V.
O.,Veli Cengiz
Ozalp,V.C.
Özalp, Cengiz
V.C.Ozalp
Cengiz Özalp, V.
Ozalp C.
Özalp, V. Cengiz
Ozalp, V. Cengiz
Ozalp V.
V., Ozalp
Ozalp, V. C.
Özalp C.
Ö., Veli Cengiz
Ö.,Veli Cengiz
Job Title
Profesor Doktor
Email Address
cengiz.ozalp@atilim.edu.tr
Main Affiliation
Basic Sciences
Status
Website
ORCID ID
0000-0002-7659-5990
Scopus Author ID
6504450287
Turkish CoHE Profile ID
Google Scholar ID
WoS Researcher ID
Scholarly Output

28

Articles

27

Citation Count

156

Supervised Theses

0

Filters

20241
Reset filters

Settings

Type: Review

Scholarly Output Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Review
    Citation - WoS: 2
    Citation - Scopus: 2
    Enhanced Selex Platforms for Aptamer Selection With Improved Characteristics: a Review
    (Springernature, 2024) Didarian, Reza; Ozbek, Hatice K.; Ozalp, Veli C.; Erel, Ozcan; Yildirim-Tirgil, Nimet; Basic Sciences
    This review delves into the advancements in molecular recognition through enhanced SELEX (Systematic Evolution of Ligands by Exponential Enrichment) platforms and post-aptamer modifications. Aptamers, with their superior specificity and affinity compared to antibodies, are central to this discussion. Despite the advantages of the SELEX process-encompassing stages like ssDNA library preparation, incubation, separation, and PCR amplification-it faces challenges, such as nuclease susceptibility. To address these issues and propel aptamer technology forward, we examine next-generation SELEX platforms, including microfluidic-based SELEX, capillary electrophoresis SELEX, cell-based aptamer selection, counter-SELEX, in vivo SELEX, and high-throughput sequencing SELEX, highlighting their respective merits and innovations. Furthermore, this article underscores the significance of post-aptamer modifications, particularly chemical strategies that enhance aptamer stability, reduce renal filtration, and expand their target range, thereby broadening their utility in diagnostics, therapeutics, and nanotechnology. By synthesizing these advanced SELEX platforms and modifications, this review illuminates the dynamic progress in aptamer research and outlines the ongoing efforts to surmount existing challenges and enhance their clinical applicability, charting a path for future breakthroughs in this evolving field.